Sales of Johnson & Johnson’s diabetes drug Invokana have suffered since the FDA slapped a boxed warning on its label detailing the product’s amputation risks. But in an about-face, the agency now says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results